Phase 4Not yet recruitingAge-related condition

Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With Minimal Subclinical Atherosclerosis (MINI-STAR)

Sponsor
Yonsei University (Academic or other)
Enrollment
300 planned
Conditions
Atherosclerosis Cardiovascular Disease
Interventions
Crezet 2.5/10mg; Litorvazet 5/10mg; Baroezet 1/10mg
Ages
adults, older adults
Registry
NCT07871604

Full record on ClinicalTrials.gov

From the registry

This study aims to compare the tolerability and metabolic safety of three low-dose statin/ezetimibe combinations (rosuvastatin/ezetimibe 2.5/10 mg, atorvastatin/ezetimibe 5/10 mg, pitavastatin/ezetimibe 1/10 mg) in patients with minimal subclinical atherosclerosis identified by imaging studies (Coronary Computed Tomography Angiography, Coronary Angiography, or carotid sonography)

Primary outcomes

  • discontinuation or drug change of the study drug due to intolerance

History

  1. Primary completion expected

  2. Started

  3. Last registry update

  4. Registered